Sacituzumab Govitecan for Advanced Esophageal Squamous Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Sacituzumab govitecan
Related studies linked through entity extraction aliases.
HCQ+ADC vs ADC in the Treatment of Advanced Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)
- Status
- RECRUITING
- Phase
- PHASE2
Sequencing Antibody Drug Conjugates in ER+/HER2 LOW/ULTRA LOW MBC
- Status
- RECRUITING
- Phase
- PHASE2
Sacituzumab Govitecan and Zimberelimab w/SRS in the Management of Metastatic Triple Negative Breast Cancer With Brain Metastases
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
HR+/HER2- Advanced or Metastatic Breast Cancer Patients Treated With Sacituzumab Govitecan
- Status
- RECRUITING
- Phase
- PHASE2
Sacituzumab govitEcan in THYroid Cancers
- Status
- RECRUITING
- Phase
- PHASE2
Sacituzumab Govitecan for the Treatment for Patients With Locally Advanced, Recurrent, or Metastatic Cholangiocarcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of GS-0201 Alone and in Combination in Participants With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Sacituzumab Govitecan With or Without Atezolizumab Immunotherapy in Rare Genitourinary Tumors (SMART) Such as High Grade Neuroendocrine Carcinomas, Adenocarcinoma, and Squamous Cell Bladder/Urinary Tract Cancer, Renal Medullary Carcinoma and Penile C...
- Status
- RECRUITING
- Phase
- PHASE2
PeRioperative Immunotherapy Combined With Sacituzumab Govitecan in Muscle Invasive blAdder Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study Evaluating Treatment of Sacituzumab-govitecan for Patients With Metastatic Esophagogastric Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Organoid-based Functional Precision Therapy for Advanced Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Single-arm Phase II Trial of SAcituzumab Govitecan and Trastuzumab for HER2+ Metastatic Breast Cancer After Trastuzumab dEruxtEcaN (SATEEN)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
NeoAdj. Therapy Comparing Sacituzumab Govitecan (SG) vs. SG+Pembrolizumab in Low-risk, Triple-neg. EBC (ADAPT-TN-III)
- Status
- RECRUITING
- Phase
- PHASE3
Neoadjuvant Sacituzumab Govitecan Plus Pembrolizumab in Resectable Non-Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Sacituzumab Govitecan (IMMU-132) in Platinum-resistant Ovarian Cancer Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Phase II Trial of Sacituzumab Govitecan in Recurrent and/or Metastatic Secretory Gland Cancers
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Sacituzumab Govitecan (IMMU-132) in Patients With Recurrent or Persistent Cervical Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Adaptive RADiation Therapy With Concurrent Sacituzumab Govitecan (SG) for Muscle Invasive Bladder Cancer
- Status
- RECRUITING
- Phase
- PHASE1